EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 27 / No 2 (Février 2011) Med Sci (Paris), 27 2 (2011) 183-186 References
Free Access
Issue
Med Sci (Paris)
Volume 27, Number 2, Février 2011
Page(s) 183 - 186
Section M/S revues
DOI https://doi.org/10.1051/medsci/2011272183
Published online 08 March 2011
  1. Civitareale D, Lonigro R, Sinclair AJ, Di Lauro R. A thyroid-specific nuclear protein essential for tissue-specific expression of the thyroglobulin promoter. EMBO J 1989 ; 8 : 2537-2542. [PubMed] [Google Scholar]
  2. Lazzaro D, Price M, de Felice M, Di Lauro R. The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. Development 1991 ; 113 : 1093-1104. [PubMed] [Google Scholar]
  3. Kimura S, Hara Y, Pineau T, et al.. The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev 1996 ; 10 : 60-69. [Google Scholar]
  4. Katoh R, Kawaoi A, Miyagi E, et al.. Thyroid transcription factor-1 in normal, hyperplastic, and neoplastic follicular thyroid cells examined by immunohistochemistry and nonradioactive in situ hybridization. Mod Pathol 2000 ; 13 : 570-576. [CrossRef] [PubMed] [Google Scholar]
  5. Bejarano PA, Nikiforov YE, Swenson ES, Biddinger PW. Thyroid transcription factor-1, thyroglobulin, cytokeratin 7, and cytokeratin 20 in thyroid neoplasms. Appl Immunohistochem Mol Morphol 2000 ; 8 : 189-194. [CrossRef] [PubMed] [Google Scholar]
  6. Ziad el A, Ruchala M, Breborowicz J, et al.. Immunoexpression of TTF-1 and Ki-67 in a coexistent anaplastic and follicular thyroid cancer with rare long-life surviving. Folia Histochem Cytobiol 2008 ; 46 : 461-464. [CrossRef] [PubMed] [Google Scholar]
  7. Ohmori M, Ohta M, Shimura H, et al. Cloning of the single strand DNA-binding protein important for maximal expression and thyrotropin (TSH)-induced negative regulation of the TSH receptor. Mol Endocrinol 1996 ; 10 : 1407-1424. [CrossRef] [PubMed] [Google Scholar]
  8. Fabbro D, Di Loreto C, Beltrami CA, et al.. Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasms. Cancer Res 1994 ; 54 : 4744-4749. [PubMed] [Google Scholar]
  9. Fenton CL, Patel A, Burch HB, Tuttle RM, Francis GL. Nuclear localization of thyroid transcription factor-1 correlates with serum thyrotropin activity and may be increased in differentiated thyroid carcinomas with aggressive clinical course. Ann Clin Lab Sci 2001 ; 31 : 245-252. [PubMed] [Google Scholar]
  10. Lv H, Zhang S, Wang B, Cui S, Yan J. Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Release 2006 ; 114 : 100-109. [CrossRef] [PubMed] [Google Scholar]
  11. Gudmundsson J, Sulem P, Gudbjartsson DF, et al. Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet 2009 ; 41 : 460-464. [CrossRef] [PubMed] [Google Scholar]
  12. Chen G, Jiang Q, You Z, et al. Regulation of GSK-3 beta in the proliferation and apoptosis of human thyrocytes investigated using a GSK-3 beta-targeting RNAi adenovirus expression vector: involvement the Wnt/beta-catenin pathway. Mol Biol Reports 2010 ; 37 : 2773-2779. [CrossRef] [Google Scholar]
  13. Bohinski RJ, Bejarano PA, Balko G, Warnick RE, Whitsett JA. Determination of lung as the primary site of cerebral metastatic adenocarcinomas using monoclonal antibody to thyroid transcription factor-1. J NeuroOncol 1998 ; 40 : 227-231. [CrossRef] [PubMed] [Google Scholar]
  14. Kwei KA, Kim YH, Girard L, et al. Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer. oncogene 2008 ; 27 : 3635-3640. [CrossRef] [PubMed] [Google Scholar]
  15. Garraway LA, Sellers WR. Lineage dependency and lineage-survival oncogenes in human cancer. Nat Rev Cancer 2006 ; 6 : 593-602. [CrossRef] [PubMed] [Google Scholar]
  16. Asa SL. My approach to oncocytic tumours of the thyroid. J Clin Pathol 2004 ; 57 : 225-232. [CrossRef] [PubMed] [Google Scholar]
  17. Oliveira AM, Tazelaar HD, Myers JL, et al. Thyroid transcription factor-1 distinguishes metastatic pulmonary from well-differentiated neuroendocrine tumors of other sites. Am J Surg Pathol 2001 ; 25 : 815-819. [CrossRef] [PubMed] [Google Scholar]
  18. Ordonez NG. Thyroid transcription factor-1 is a marker of lung and thyroid carcinomas. Adv Anat Pathol 2000 ; 7 : 123-127. [CrossRef] [PubMed] [Google Scholar]
  19. Jagirdar J. Application of immunohistochemistry to the diagnosis of primary and metastatic carcinoma to the lung. Arch Pathol Lab Med 2008 ; 132 : 384-396. [PubMed] [Google Scholar]
  20. Marchevsky AM. Application of immunohistochemistry to the diagnosis of malignant mesothelioma. Arch Pathol Lab Med 2008 ; 132 : 397-401. [PubMed] [Google Scholar]
  21. Byrd-Gloster AL, Khoor A, Glass LF, et al. Differential expression of thyroid transcription factor 1 in small cell lung carcinoma and Merkel cell tumor. Hum Pathol 2000 ; 31 : 58-62. [CrossRef] [PubMed] [Google Scholar]
  22. Puglisi F, Aprile G, Bruckbauer M, et al. Combined analysis of MIB-1 and thyroid transcription factor-1 predicts survival in non-small cell lung carcinomas. Cancer Lett 2001 ; 162 : 97-103. [CrossRef] [PubMed] [Google Scholar]
  23. Barletta JA, Perner S, Iafrate AJ, et al. Clinical significance of TTF-1 protein expression and TTF-1 gene amplification in lung adenocarcinoma. J Cell Mol Med 2009 ; 13 : 1977-1986. [CrossRef] [PubMed] [Google Scholar]
  24. Anagnostou VK, Syrigos KN, Bepler G, et al. Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinoma. J Clin Oncol 2009 ; 27 : 271-278. [CrossRef] [PubMed] [Google Scholar]
  25. Kitamura H, Yazawa T, Sato H, et al. Small cell lung cancer: significance of RB alterations and TTF-1 expression in its carcinogenesis, phenotype, and biology. Endocr Pathol 2009 ; 20 : 101-107. [CrossRef] [PubMed] [Google Scholar]
  26. Zhang P, Zuo H, Nakamura Y, et al. Immunohistochemical analysis of thyroid-specific transcription factors in thyroid tumors. Pathol Int 2006 ; 56 : 240-245. [CrossRef] [PubMed] [Google Scholar]
  27. Ngan ES, Lang BH, Liu T, et al.. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma. J Natl Cancer Inst 2009 ; 101 : 162-175. [CrossRef] [PubMed] [Google Scholar]
  28. Puglisi F, Barbone F, Damante G, et al. Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma. Mod Pathol 1999 ; 12 : 318-324. [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.